Pharma bro Martin Shkreli convicted of fraud, victory pharma.#Victory #pharma


Posted On Jan 14 2018 by

‘Pharma bro’ Martin Shkreli convicted of fraud

ASX winners and losers – a snapshot

Victory pharma

More BusinessDay Videos

Victory pharma

Why Martin Shkreli Is on trial for making .

Why Martin Shkreli Is on trial for making millions

Up Next

ASX winners and losers – a snapshot

Victory pharma

Victory pharma

ASX winners and losers – a snapshot

ASX winners and losers – a snapshot

Up Next

Uber comes clean on hack

Victory pharma

Victory pharma

Uber comes clean on hack

Uber comes clean on hack

Up Next

PM is holding his ground

Victory pharma

Victory pharma

PM is holding his ground

PM is holding his ground

Up Next

Uber’s uncertain future

Victory pharma

Victory pharma

Uber’s uncertain future

Uber’s uncertain future

Up Next

AT width: 250px; margin: 0 10px 5px 0;” src=”https://www.fairfaxstatic.com.au/content/dam/images/g/x/p/x/9/z/image.related.articleLeadwide.380×214.gxpx9s.png/1501875342763.jpg” /> Martin Shkreli, former chief executive officer of Turing Pharmaceuticals, arrives at federal court in New York on Friday. Photo: Bloomberg

You will now receive updates from Business AM Newsletter

Business AM Newsletter

Get the latest news and updates emailed straight to your inbox.

By submitting your email you are agreeing to Fairfax Media’s terms and conditions and privacy policy.

Prosecutors claimed that between 2009 and 2014, Shkreli lied to MSMB investors, lost their money and paid them back with cash and stock misappropriated from Retrophin.

Jurors heard testimony from several MSMB investors who said Shkreli falsely claimed to have an outside auditor and tens of millions of dollars in assets, sent them fabricated account statements after losing their money and became evasive when they asked for their investments back.

Prosecutors said Shkreli eventually paid investors back with stock or cash from Retrophin by having them sign settlement or consulting agreements with the company. Retrophin directors testified that they did not approve those agreements in advance.

Shkreli’s lawyer, Benjamin Brafman, had urged jurors to see his client not as a fraudster but as an eccentric genius determined to find cures for rare diseases.

Brafman said that while Shkreli’s statements to investors were not always true, he made them in good faith. He also emphasised that none of Shkreli’s investors lost money, a rarity in a securities fraud case.


Last Updated on: January 14th, 2018 at 8:17 am, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *